James O Burton Selected Research

Myocardial Stunning (Stunned Myocardium)

10/2017	Potentially pathogenic circulating autoantibodies to cardiac troponin are present in hemodialysis patients.
1/2013	N-terminal Pro-B-type natriuretic peptide and its correlation to haemodialysis-induced myocardial stunning.
8/2012	Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients.
1/2011	Individualised dialysate temperature improves intradialytic haemodynamics and abrogates haemodialysis-induced myocardial stunning, without compromising tolerability.
1/2011	Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease.
5/2009	Hemodialysis-induced cardiac injury: determinants and associated outcomes.
1/2008	Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James O Burton Research Topics

Disease

11	Inflammation (Inflammations) 03/2022 - 01/2011
9	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 10/2016
8	Chronic Renal Insufficiency 01/2022 - 01/2015
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2010
7	Myocardial Stunning (Stunned Myocardium) 10/2017 - 01/2008
6	Ischemia 01/2011 - 11/2006
5	Hypotension (Low Blood Pressure) 01/2011 - 11/2006
4	Fibrosis (Cirrhosis) 07/2021 - 10/2016
3	Necrosis 01/2022 - 01/2015
3	Malnutrition (Nutritional Deficiencies) 01/2019 - 01/2012
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2010 - 01/2008
2	Hemorrhage 01/2022 - 01/2021
2	Hyperphosphatemia 11/2020 - 09/2015
2	Uremia 01/2020 - 01/2019
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2016 - 01/2008
2	Left Ventricular Dysfunction 01/2008 - 11/2006
1	Syndrome (Syndromes) 01/2022
1	Pruritus (Itching) 01/2022
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Stroke (Strokes) 01/2022
1	Edema (Dropsy) 07/2021
1	Alopecia (Baldness) 03/2021
1	COVID-19 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Arteriovenous Fistula 01/2021
1	Secondary Hyperparathyroidism 01/2021
1	Anemia 01/2019
1	Bone Diseases (Bone Disease) 01/2018
1	Infections 01/2018
1	Thrombosis (Thrombus) 01/2018
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2018
1	Cardiomyopathies (Cardiomyopathy) 10/2017
1	Sclerosis 07/2017
1	Atherosclerotic Plaque (Atheroma) 01/2015
1	Acute Coronary Syndrome 01/2015
1	Fabry Disease (Fabry's Disease) 07/2012
1	Proteinuria 01/2011
1	Atherosclerosis 01/2011
1	Sudden Death 01/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2008
1	Heart Failure 01/2008
1	Cardiac Arrhythmias (Arrythmia) 01/2008

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2022 - 01/2011
3	EndotoxinsIBA 01/2022 - 01/2011
3	C-Reactive ProteinIBA 01/2022 - 01/2011
3	Troponin T (Troponin T1)IBA 08/2012 - 05/2009
3	Dialysis SolutionsIBA 01/2011 - 11/2006
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2017
2	Phosphates (Orthophosphate)IBA 09/2020 - 09/2015
2	LipidsIBA 01/2020 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 08/2017 - 02/2017
2	Glucose (Dextrose)FDA LinkGeneric 07/2017 - 01/2010
1	Therapeutic UsesIBA 03/2022
1	Thromboplastin (Tissue Factor)IBA 03/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Warfarin (Coumadin)FDA LinkGeneric 03/2021
1	AnticoagulantsIBA 03/2021
1	apixabanIBA 03/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	IronIBA 01/2021
1	CoagulantsIBA 11/2020
1	PrebioticsIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	MicroRNAs (MicroRNA)IBA 11/2018
1	MineralsIBA 01/2018
1	AutoantibodiesIBA 10/2017
1	TroponinIBA 10/2017
1	Advanced Glycation End ProductsIBA 07/2017
1	Guanosine Diphosphate (GDP)IBA 07/2017
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 09/2015
1	tetra-(4-aminophenyl)porphyrinIBA 01/2015
1	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2015
1	Muscle Proteins (Muscle Protein)IBA 01/2013
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2013
1	EnzymesIBA 07/2012
1	GalactosidasesIBA 07/2012
1	Erythropoietin FDA Link 01/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2010
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2010

Therapy/Procedure

19	Renal Dialysis (Hemodialysis) 01/2022 - 11/2006
6	Therapeutics 01/2022 - 10/2016
2	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2019 - 12/2017
1	Nephrectomy 11/2020
1	Peritoneal Dialysis 01/2020
1	Terminal Care (Care, Terminal) 01/2015
1	Psychology Biofeedback (Biofeedback) 01/2008